DE602005013957D1 - Verfahren zur durchführung von vollbluttests - Google Patents

Verfahren zur durchführung von vollbluttests

Info

Publication number
DE602005013957D1
DE602005013957D1 DE602005013957T DE602005013957T DE602005013957D1 DE 602005013957 D1 DE602005013957 D1 DE 602005013957D1 DE 602005013957 T DE602005013957 T DE 602005013957T DE 602005013957 T DE602005013957 T DE 602005013957T DE 602005013957 D1 DE602005013957 D1 DE 602005013957D1
Authority
DE
Germany
Prior art keywords
methods
disclosed
blood tests
performing full
full blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005013957T
Other languages
English (en)
Inventor
Mark A Billadeau
Jeff D Debad
Eli N Glezer
Jonathan K Leland
Charles A Wijayawardhana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meso Scale Technologies LLC
Original Assignee
Meso Scale Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meso Scale Technologies LLC filed Critical Meso Scale Technologies LLC
Publication of DE602005013957D1 publication Critical patent/DE602005013957D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521—Single-layer analytical elements
    • G01N33/523—Single-layer analytical elements the element being adapted for a specific analyte
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/11—Automated chemical analysis
    • Y10T436/117497—Automated chemical analysis with a continuously flowing sample or carrier stream
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
DE602005013957T 2004-06-03 2005-06-03 Verfahren zur durchführung von vollbluttests Active DE602005013957D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57671004P 2004-06-03 2004-06-03
PCT/US2005/019498 WO2005121798A1 (en) 2004-06-03 2005-06-03 Methods and apparatuses for conducting assays

Publications (1)

Publication Number Publication Date
DE602005013957D1 true DE602005013957D1 (de) 2009-05-28

Family

ID=34982224

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005013957T Active DE602005013957D1 (de) 2004-06-03 2005-06-03 Verfahren zur durchführung von vollbluttests

Country Status (6)

Country Link
US (3) US7776583B2 (de)
EP (1) EP1766400B1 (de)
AT (1) ATE428931T1 (de)
DE (1) DE602005013957D1 (de)
DK (1) DK1766400T3 (de)
WO (1) WO2005121798A1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ580449A (en) * 2003-09-11 2011-06-30 Theranos Inc Ingestible medical device with biocompatible polymer coating, device with microarray to interact with disease marker
ATE428931T1 (de) * 2004-06-03 2009-05-15 Meso Scale Technologies Llc Verfahren zur durchführung von vollbluttests
AU2005252853B2 (en) * 2004-06-07 2010-10-14 Abbott Rapid Diagnostics International Unlimited Company Method
EP1836495A2 (de) * 2004-11-17 2007-09-26 BioVeris Corporation Elektrochemilumineszente untersuchung
GB0503836D0 (en) * 2005-02-24 2005-04-06 Axis Shield Asa Method
KR101381331B1 (ko) 2005-05-09 2014-04-04 테라노스, 인코포레이티드 현장진료 유체 시스템 및 그 용도
US20060275852A1 (en) * 2005-06-06 2006-12-07 Montagu Jean I Assays based on liquid flow over arrays
US8741230B2 (en) 2006-03-24 2014-06-03 Theranos, Inc. Systems and methods of sample processing and fluid control in a fluidic system
US11287421B2 (en) 2006-03-24 2022-03-29 Labrador Diagnostics Llc Systems and methods of sample processing and fluid control in a fluidic system
US8007999B2 (en) 2006-05-10 2011-08-30 Theranos, Inc. Real-time detection of influenza virus
US20080113391A1 (en) 2006-11-14 2008-05-15 Ian Gibbons Detection and quantification of analytes in bodily fluids
JP2010524004A (ja) * 2007-04-12 2010-07-15 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 微粒子を分析するためのシステムおよび方法
WO2009009630A1 (en) * 2007-07-11 2009-01-15 Clemson University Photoluminescent materials for multiphoton imaging
US8158430B1 (en) 2007-08-06 2012-04-17 Theranos, Inc. Systems and methods of fluidic sample processing
CA2701380C (en) * 2007-10-01 2014-03-11 University Of Southern California Detection of methylated dna and dna mutations
SE533515C2 (sv) 2008-04-16 2010-10-12 Aamic Ab Analysförfarande för samtidig analys av flera analyter
US20100204062A1 (en) * 2008-11-07 2010-08-12 University Of Southern California Calibration methods for multiplexed sensor arrays
US20100135855A1 (en) * 2008-11-26 2010-06-03 Koninklijke Philips Electronics N.V. Method for depositing substances on a support
WO2010115143A1 (en) * 2009-04-03 2010-10-07 University Of Southern California Surface modification of nanosensor platforms to increase sensitivity and reproducibility
US8862448B2 (en) 2009-10-19 2014-10-14 Theranos, Inc. Integrated health data capture and analysis system
WO2011062738A1 (en) 2009-11-23 2011-05-26 Mikhail Briman Controlled electrochemical activation of carbon-based electrodes
CN102713636B (zh) * 2010-01-29 2015-06-17 美迪恩斯生命科技株式会社 人sCD14-ST的分析方法
WO2011146881A1 (en) * 2010-05-20 2011-11-24 University Of Southern California Pan-antibody assays - principles, methods, and devices
WO2012051519A2 (en) 2010-10-14 2012-04-19 The Johns Hopkins University Biomarkers of brain injury
EP2661485A4 (de) 2011-01-06 2018-11-21 Meso Scale Technologies, LLC Testkassetten und verfahren zu ihrer verwendung
EP2527814A1 (de) * 2011-04-27 2012-11-28 Koninklijke Philips Electronics N.V. Sensorsystem mit austauschbarer Patrone und Lesegerät
EP2707389B1 (de) 2011-05-12 2019-10-30 The Johns Hopkins University Testreagenzien für eine neurogranin-diagnosekit
EP2737315B1 (de) 2011-07-25 2022-03-16 Proxim Diagnostics Corporation Kartusche für diagnostische tests
JP6362543B2 (ja) * 2012-02-23 2018-07-25 ジュノ セラピューティクス ゲーエムベーハー 細胞および他の複雑な生物学的材料のクロマトグラフィーによる単離
US9625465B2 (en) 2012-05-15 2017-04-18 Defined Diagnostics, Llc Clinical diagnostic systems
US9213043B2 (en) 2012-05-15 2015-12-15 Wellstat Diagnostics, Llc Clinical diagnostic system including instrument and cartridge
US9081001B2 (en) * 2012-05-15 2015-07-14 Wellstat Diagnostics, Llc Diagnostic systems and instruments
US20150025004A1 (en) * 2013-02-27 2015-01-22 Meso Scale Technologies, Llc Kidney function biomarkers
US9458488B2 (en) 2013-03-15 2016-10-04 Nanomix, Inc. Point of care sensor systems
WO2015009907A1 (en) 2013-07-17 2015-01-22 The Johns Hopkins University A multi-protein biomarker assay for brain injury detection and outcome
PL3132247T3 (pl) 2014-04-16 2022-01-03 Juno Therapeutics Gmbh Sposoby, zestawy i urządzenie do namnażania populacji komórek
US10222386B2 (en) 2014-09-19 2019-03-05 The Johns Hopkins University Biomarkers of congnitive dysfunction
EP3259594A4 (de) 2015-02-20 2018-12-26 The Johns Hopkins University Biomarker für myokardläsion
JP7195141B2 (ja) 2015-10-22 2022-12-23 ジュノ セラピューティクス ゲーエムベーハー 形質導入のための方法、キット、作用物質および装置
MA45488A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés, kits et appareil de culture de cellules
MA45489A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés de culture de cellules, kits et appareil associés
US10088494B2 (en) * 2016-01-25 2018-10-02 Perkinelmer Health Sciences, Inc. Method and system for microfluidic sample analysis
US11866465B2 (en) 2017-04-27 2024-01-09 Juno Therapeutics Gmbh Oligomeric particle reagents and methods of use thereof
CN112272775A (zh) 2018-06-04 2021-01-26 雅芳产品公司 用于鉴定和治疗衰老皮肤和皮肤病症的蛋白生物标志物
US20220082561A1 (en) * 2018-09-20 2022-03-17 Worcester Polytechnic Institute Methods to capture cells based on preferential adherence
WO2020061369A1 (en) * 2018-09-20 2020-03-26 Siemens Healthcare Diagnostics Inc. Methods and apparatus for hiln determination with a deep adaptation network for both serum and plasma samples
EP4143576A1 (de) 2020-05-01 2023-03-08 Meso Scale Technologies, LLC Serologische virusassays
WO2021236584A1 (en) 2020-05-19 2021-11-25 Meso Scale Technologies, Llc. Methods, compositions, and kits for nucleic acid detection
EP4323546A1 (de) 2021-04-16 2024-02-21 Meso Scale Technologies, LLC Verfahren, zusammensetzungen und kits zum nachweis der hydrolaseenzymaktivität
EP4341692A1 (de) 2021-05-21 2024-03-27 Meso Scale Technologies, LLC Serologische tests für virenstämme
CA3225576A1 (en) 2021-06-28 2023-01-05 Meso Scale Technologies, Llc. Methods, compositions, and kits for assay signal amplification
WO2023245184A1 (en) 2022-06-17 2023-12-21 Meso Scale Technologies, Llc. Viral strain serology assays
WO2024064904A1 (en) 2022-09-23 2024-03-28 Meso Scale Technologies, Llc. Orthopoxvirus serology assays

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE388694B (sv) 1975-01-27 1976-10-11 Kabi Ab Sett att pavisa ett antigen exv i prov av kroppvetskor, med utnyttjande av till porost berarmaterial bundna eller adsorberande antikroppar
US4235601A (en) 1979-01-12 1980-11-25 Thyroid Diagnostics, Inc. Test device and method for its use
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4442204A (en) 1981-04-10 1984-04-10 Miles Laboratories, Inc. Homogeneous specific binding assay device and preformed complex method
US5208535A (en) 1990-12-28 1993-05-04 Research Development Corporation Of Japan Mr position detecting device
US5460945A (en) * 1991-05-30 1995-10-24 Center For Blood Research, Inc. Device and method for analysis of blood components and identifying inhibitors and promoters of the inflammatory response
SE9401102D0 (sv) 1994-03-31 1994-03-31 Pharmacia Biosensor Ab Assay method
DE69819996T2 (de) 1997-09-27 2004-09-02 Horiba Ltd. Gerät für die Zählung von Blutzellen und zur immunologischen Bestimmung unter Verwendung von Vollblut
US6475372B1 (en) 2000-02-02 2002-11-05 Lifescan, Inc. Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations
US6383748B1 (en) * 1999-09-14 2002-05-07 Pamgene B.V. Analytical test device with substrate having oriented through going channels and improved methods and apparatus for using same
CN102620959B (zh) 2002-12-26 2015-12-16 梅索磅秤技术有限公司 检定盒及其使用方法
ATE428931T1 (de) * 2004-06-03 2009-05-15 Meso Scale Technologies Llc Verfahren zur durchführung von vollbluttests

Also Published As

Publication number Publication date
US7776583B2 (en) 2010-08-17
US8343526B2 (en) 2013-01-01
EP1766400A1 (de) 2007-03-28
DK1766400T3 (da) 2009-07-20
WO2005121798A1 (en) 2005-12-22
ATE428931T1 (de) 2009-05-15
EP1766400B1 (de) 2009-04-15
US8273566B2 (en) 2012-09-25
US20100267063A1 (en) 2010-10-21
US20120034645A1 (en) 2012-02-09
US20060019319A1 (en) 2006-01-26

Similar Documents

Publication Publication Date Title
DE602005013957D1 (de) Verfahren zur durchführung von vollbluttests
DE502004008216D1 (de) Vorrichtung und verfahren zur simultanen durchführung von blutgruppenbestimmung, serumgegenprobe und antikörpersuch-test
SE0303249D0 (sv) Hematocrit and analyte concentration determination
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
WO2007041692A3 (en) Microfluidic detection of analytes
ATE554168T1 (de) Integriertes mikrofluidisches bauteil zum aufreinigen von analytmolekülen sowie verfahren zum aufreinigen
WO2004011607A3 (en) Reagent and method for determination of a substance using an immunoaggregator
WO2003106623A3 (en) NON-EFFECTIVE PRENATAL EARLY TESTING FOR DETECTION OF EARTHPLUSTS AND HEREDITARY CONDITIONS
DE602005015299D1 (de) Verfahren, chip, vorrichtung und integriertes system zum nachweis biologischer partikel
ATE428929T1 (de) Reagens, ausstattung und verfahren zur probenanalyse
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
ATE553216T1 (de) Sonden, bibliotheken und kits zur analyse von nukleinsäuregemischen und verfahren zu deren konstruktion
EP2144064A3 (de) Zusammensetzungen und Verfahren zur Modulation des Lignins einer Pflanze
WO2008117067A8 (en) Protein signature/markers for the detection of adenocarcinoma
ATE408829T1 (de) Verfahren und assaykits zum nachweis mononuklearer zellphänotypen
WO2006051548A3 (en) Blood type method system and device
WO2005024384A3 (en) Devices and methods for separating phospholipids from biological samples
ATE421095T1 (de) Porosität und biologische aktivität beibehaltende haftmembranen in einer assay-einrichtung zur messung von serum cholesterin in assoziation mit hochdichten lipoproteinen
EP3736571A4 (de) Verfahren, reagenz und chip zur messung der analytkonzentration in einer biologischen probe
ATE378591T1 (de) Verfahren und vorrichtung zur vorhersage von kardiovaskulären ereignissen
ATE416384T1 (de) Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe
MX2015013596A (es) Metodos, dispositivos y sistemas para analisis de muestras.
ATE360213T1 (de) Bestimung und quantifizierung von erythrocytenpopulationen in proben
ATE415484T1 (de) Verfahren und zusammensetzungen zur charakterisierung eines redox-reagenz-system enzyms
ATE449341T1 (de) Verfahren zur quantifizierung einer bestimmten zellpopulation in einer menschlichen blutprobe

Legal Events

Date Code Title Description
8364 No opposition during term of opposition